Ammonia N 13 - 2007 FDA approvals

Drug: Ammonia N 13
Indication: PET scanning
Company: Feinstein
Approval Date: August 27, 2007

Scoop: Feinstein's Ammonia N 13 is a radiopharmaceuticals that allows physicians to get a clearer look inside the human body during PET scans. The approval is for PET imaging of the myocardium to diagnose suspected or existing coronary heart disease.

Ammonia N 13 - 2007 FDA approvals
Read more on

Suggested Articles

What a difference a day makes in biotech.

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing.

A drug developed at Temple restores a mechanism in brain cells that prevents the toxic buildup of the proteins amyloid beta and tau in Alzheimer's.